Pancreatic Cancer Research

ResearcherCentre pour l'innovation en cancérologie de LyonActive in the last 2 years

Benoît You

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3177-8857; OpenAlex author ID A5073787373. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
2 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2013: 1 trial · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 trial · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 1

  1. Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer. Co-author DOI 10.1056/nejmoa2600752↗

Trials 2

  1. Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients Principal investigator NCT03787056↗
  2. EVESOR: a Phase 1 Trial of Everolimus and Sorafenib Study director NCT01932177↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wungki Park · 1 shared paper, 2026 · strength 0.19
  2. Antoîne Italiano · 1 shared paper, 2026 · strength 0.19
  3. Hirokazu Shoji · 1 shared paper, 2026 · strength 0.19
  4. Antoine Hollebecque · 1 shared paper, 2026 · strength 0.19
  5. Makoto Ueno · 1 shared paper, 2026 · strength 0.19
  6. Anup Kasi · 1 shared paper, 2026 · strength 0.19
  7. Patricia Mucci LoRusso · 1 shared paper, 2026 · strength 0.19
  8. Jordan D. Berlin · 1 shared paper, 2026 · strength 0.19
  9. Pasi Antero Janne · 1 shared paper, 2026 · strength 0.19
  10. Christos K Fountzilas · 1 shared paper, 2026 · strength 0.19
  11. Philippe Alexandre Cassier · 1 shared paper, 2026 · strength 0.19
  12. Jonathan Wade Goldman · 1 shared paper, 2026 · strength 0.19
  13. Alexander I. Spira · 1 shared paper, 2026 · strength 0.19
  14. Teresa Mercade Macarulla · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.